Figure 8.

Numbers of CTCs per 7.5ml of patient blood samples based on treatment response. a) Median CTC numbers detected by RareCyte® system for baseline (n= 26), progression group (n= 47), stable disease group (n= 26), and response group (n= 49). Values expressed as Median (IQR), a significant difference was assessed using the Kruskal-Wallis test.